KINETICS OF MUSCLE METABOLISM BY POSITRON TRACERS

正电子示踪剂的肌肉代谢动力学

基本信息

项目摘要

Positron emission tomography (PET) of regional blood flow and metabolism in heart, brain and neoplastic tissue has introduced a new class of tracers to record cellular events in intact, functioning organs without destruction of the tissue. At the present time, further development of the PET technique is hampered by its semi-quantitative nature. The broad objective of this project is to exploit the unique characteristics of positron emitting isotopes for the quantitative study of muscle metabolism and for the correlation between metabolism and function in vivo. Prior experiments have demonstrated the utility of the glucose analog [18F]-2-deoxy-2-fluoro-D-glucose (FDG) for the rapid kinetic analysis of glucose uptake by heart and skeletal muscle as it relates to organ function, but the technique requires further validation. Radioactivity in the tissue is measured together with the FDG input function on a second-by-second basis. This technique not only provides reliable data for kinetic modeling, but also a means to test the hypothesis that there is a feedback system to match work and substrate C3 utilization on a beat-to-beat time scale. The isolated working rat heart will be used to correlate the kinetics of tracer uptake with direct measurements of the rate of glucose utilization under control conditions and after specific perturbations including competing substrates, stimulation of glucose transport by insulin, and ischemia/reperfusion. In vivo application of the technique to skeletal muscle will utilize the rabbit hindlimb under control conditions and during euglycemic/hyperinsulinemic clamps or during periods of increased contractile activity. For both hearts and skeletal muscle, differences in the kinetics of the analog and glucose in terms of intracellular phosphorylation and dephosphorylation will be assessed by direct biochemical measurements of the Km and Vmax of hexokinase and glucose 6-phosphatase for glucose and FDG. These analyses seek direct evidence for changes in key components of the correction factor relating tracer to tracee (lumped constant). Measurements of enzyme activities and intracellular metabolite levels will be used to assess the validity of the kinetic analyses. It is expected that we will obtain quantitative data on glucose metabolism in vivo which, in turn, provide critical information on the action of insulin in muscle as well as substrate metabolism and parameters of tissue viability on reperfusion of ischemic myocardium.
局部血流和代谢的正电子发射断层扫描(PET) 在心脏、脑和肿瘤组织中引入了一类新的示踪剂 在完整的功能器官中记录细胞活动而不被破坏 的组织。目前,PET的进一步发展 技术受到其半定量性质的阻碍。其广泛目标 是利用正电子的独特特性 用于肌肉代谢的定量研究和用于 体内代谢和功能之间的相关性。先前实验 已经证明了葡萄糖类似物的效用 [18 F]-2-脱氧-2-氟-D-葡萄糖(FDG)用于快速动力学分析 心脏和骨骼肌的葡萄糖摄取,因为它与器官有关 功能,但该技术需要进一步验证。中放射性 组织与FDG输入功能一起在 一秒一秒地这项技术不仅为我们提供了可靠的数据, 动力学建模,但也是一种手段来测试假设,有一个 反馈系统,以匹配工作和底物C3利用率, 节拍到节拍的时间尺度。离体工作大鼠心脏将用于 将示踪剂吸收的动力学与直接测量相关联 在控制条件下和特定条件下 干扰,包括竞争性底物、葡萄糖刺激 胰岛素转运和缺血/再灌注。体内应用 骨骼肌技术将利用兔后肢在控制下 条件和正常血糖/高胰岛素钳夹期间或月经期间 收缩活动增强的迹象对于心脏和骨骼肌, 类似物和葡萄糖在动力学方面的差异 细胞内磷酸化和去磷酸化将通过 己糖激酶的Km和Vmax的直接生物化学测量, 葡萄糖和FDG的葡萄糖6-磷酸酶。这些分析旨在直接 有关修正系数关键组成部分变化的证据 Tracer to Tracee(集总常数)酶活性的测量和 细胞内代谢物水平将用于评估 动力学分析预计我们将获得有关的定量数据, 体内葡萄糖代谢,这反过来又提供了关于 胰岛素在肌肉中作用以及底物代谢, 缺血心肌再灌注的组织活力参数。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HEINRICH TAEGTMEYER其他文献

HEINRICH TAEGTMEYER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HEINRICH TAEGTMEYER', 18)}}的其他基金

GLUCOLIPOTOXICITY AND CARDIAC DYSFUNCTION IN OBESITY
肥胖引起的葡萄糖毒性和心脏功能障碍
  • 批准号:
    7204647
  • 财政年份:
    2005
  • 资助金额:
    $ 23.57万
  • 项目类别:
Glucolipotoxicity and Cardiac Dysfunction in Obesity
肥胖症中的糖脂毒性和心脏功能障碍
  • 批准号:
    6804107
  • 财政年份:
    2003
  • 资助金额:
    $ 23.57万
  • 项目类别:
Glucolipotoxicity and Cardiac Dysfunction in Obesity
肥胖症中的糖脂毒性和心脏功能障碍
  • 批准号:
    6942711
  • 财政年份:
    2003
  • 资助金额:
    $ 23.57万
  • 项目类别:
Glucolipotoxicity and Cardiac Dysfunction in Obesity
肥胖症中的糖脂毒性和心脏功能障碍
  • 批准号:
    7262535
  • 财政年份:
    2003
  • 资助金额:
    $ 23.57万
  • 项目类别:
Glucolipotoxicity and Cardiac Dysfunction in Obesity
肥胖症中的糖脂毒性和心脏功能障碍
  • 批准号:
    7098727
  • 财政年份:
    2003
  • 资助金额:
    $ 23.57万
  • 项目类别:
Glucolipotoxicity and Cardiac Dysfunction in Obesity
肥胖症中的糖脂毒性和心脏功能障碍
  • 批准号:
    6602591
  • 财政年份:
    2003
  • 资助金额:
    $ 23.57万
  • 项目类别:
KINETICS OF MUSCLE METABOLISM BY POSITRON TRACERS
正电子示踪剂的肌肉代谢动力学
  • 批准号:
    6613961
  • 财政年份:
    2002
  • 资助金额:
    $ 23.57万
  • 项目类别:
SWITCHING OF METABOLIC GENES IN UNLOADED HEART
空载心脏中代谢基因的转换
  • 批准号:
    6530709
  • 财政年份:
    1999
  • 资助金额:
    $ 23.57万
  • 项目类别:
SWITCHING OF METABOLIC GENES IN UNLOADED HEART
空载心脏中代谢基因的转换
  • 批准号:
    6637503
  • 财政年份:
    1999
  • 资助金额:
    $ 23.57万
  • 项目类别:
Atrophic Remodeling of the Cardiomyocyte
心肌细胞的萎缩重塑
  • 批准号:
    7620354
  • 财政年份:
    1999
  • 资助金额:
    $ 23.57万
  • 项目类别:

相似海外基金

Brain metabolism across the lifespan using multi-parametric MRS
使用多参数 MRS 分析整个生命周期的脑代谢
  • 批准号:
    10738647
  • 财政年份:
    2023
  • 资助金额:
    $ 23.57万
  • 项目类别:
Quantifying the Brain Metabolism Underlying Task-Based BOLD Imaging
量化基于任务的 BOLD 成像背后的大脑代谢
  • 批准号:
    10432379
  • 财政年份:
    2022
  • 资助金额:
    $ 23.57万
  • 项目类别:
Novel 10.5 T deuterium-based MRS/I method to measure brain metabolism
测量脑代谢的新型 10.5 T 氘 MRS/I 方法
  • 批准号:
    10442075
  • 财政年份:
    2022
  • 资助金额:
    $ 23.57万
  • 项目类别:
Neuroimaging study of the effects of phospholipase A2 (PLA2) inhibition on brain metabolism and neuroinflammation in a rat model of Alzheimer’s Disease.
神经影像学研究磷脂酶 A2 (PLA2) 抑制对阿尔茨海默病大鼠模型脑代谢和神经炎症的影响。
  • 批准号:
    486273
  • 财政年份:
    2022
  • 资助金额:
    $ 23.57万
  • 项目类别:
    Studentship Programs
Dynamics of Cellular Brain Metabolism Using Mass Spectrometry Imaging
使用质谱成像研究细胞脑代谢动力学
  • 批准号:
    10556434
  • 财政年份:
    2022
  • 资助金额:
    $ 23.57万
  • 项目类别:
In vivo MRI Measures of Brain Metabolism in Traumatic Brain Injury
创伤性脑损伤中脑代谢的体内 MRI 测量
  • 批准号:
    10444479
  • 财政年份:
    2022
  • 资助金额:
    $ 23.57万
  • 项目类别:
Quantifying the Brain Metabolism Underlying Task-Based BOLD Imaging
量化基于任务的 BOLD 成像背后的大脑代谢
  • 批准号:
    10816746
  • 财政年份:
    2022
  • 资助金额:
    $ 23.57万
  • 项目类别:
Dynamics of cellular brain metabolism using mass spectrometry imaging
使用质谱成像研究细胞脑代谢动力学
  • 批准号:
    10418219
  • 财政年份:
    2022
  • 资助金额:
    $ 23.57万
  • 项目类别:
Brain metabolism during task-evoked and spontaneous activity in aging and Alzheimer's disease
衰老和阿尔茨海默病中任务诱发和自发活动期间的大脑代谢
  • 批准号:
    10585419
  • 财政年份:
    2022
  • 资助金额:
    $ 23.57万
  • 项目类别:
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
PhytoSERM 预防更年期相关脑代谢和认知能力下降的功效:双盲、随机、安慰剂对照 2 期临床试验
  • 批准号:
    10560591
  • 财政年份:
    2022
  • 资助金额:
    $ 23.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了